In silico and in vitro evaluation of risedronate as a DKK1 antagonist: Implications for neuroprotection through DKK1–LRP6 modulation
Open Access
- 14 May 2026
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1026, 178971
Abstract
No abstract availableKeywords
Funding Information
- Manipal Academy of Higher Education
- All India Council for Technical Education (RPS-NDF 8\u201335/RIFD/RPS-NDF/POLICY-1/2018\u201319)
- Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education
This publication has 57 references indexed in Scilit:
- Voglibose Attenuates Amyloid Beta–Induced Memory Deficits in a Rodent Model: A Potential Alzheimer’s Therapy via Wnt Signaling ModulationMolecular Neurobiology, 2025
- Enhancing motor functional recovery in spinal cord injury through pharmacological inhibition of Dickkopf-1 with BHQ880 antibodyBiomedicine & Pharmacotherapy, 2024
- Recent advances to Neuroprotection: repurposing drugs against neuroinflammatory disordersMolecular Biology Reports, 2023
- Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent PainDrugs, 2022
- Gauging the role and impact of drug interactions and repurposing in neurodegenerative disordersCurrent Research in Pharmacology and Drug Discovery, 2021
- Neuroprotective role of alendronate against APP processing and neuroinflammation in mice fed a high fat dietBrain Research Bulletin, 2020
- Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic ModalitiesCell, 2017
- Computationally Design of Inhibitory Peptides Against Wnt Signaling Pathway: In Silico Insight on Complex of DKK1 and LRP6International Journal of Peptide Research and Therapeutics, 2017
- Reversal of Synapse Degeneration by Restoring Wnt Signaling in the Adult HippocampusCurrent Biology, 2016
- Excitotoxicity effects of glutamate on human neuroblastoma SH-SY5Y cells via oxidative damageNeuroscience Bulletin, 2010